CCL18 and ovarian cancer: Other chemokines potentially involved in cancer progression include CCL18, which promoted ovarian cancer migration (37), CCL20, which promoted both metastasis (38) and chemotherapy resistance (39), and CXCL8 (IL-8), which may contribute to peritoneal metastasis (40).